UNS unilife corporation
Add to My Watchlist 0.00% ! 0.5¢

Funding from Regeneron has been my hope. Sarilumab is scheduled...

  1. Gurty Baller
    479 Posts.
    clock Created with Sketch.
    29/03/17
    06:43
    Post #: 23693703
    Funding from Regeneron has been my hope. Sarilumab is scheduled for approval in the second quarter and the clinical preference study between AI and PFS has been completed, but I don't think a pharmacokinetics trial has been conducted. I have debated if a WI would be appropriate for someone with AD. AI or WI I am happy with either one or both.
    UNS Price at posting: 4.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.